Obsidian Therapeutics Inc.
Support and Resistance Levels
Past performance
News About OBX
All events for OBX
All deals for OBX
Financial Ratios
Financial Statements
OBX vs Sector & Peers
About Obsidian Therapeutics Inc.
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs. Website obsidiantx.com
Headquarters Cambridge, MA, US